Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals

GoodRx Holdings (NASDAQ:GDRX), a prescription savings platform in the U.S., has released its latest Weight Loss Medications Tracker, revealing a sharp increase in the use of popular weight loss drugs like Eli Lilly And Co’s (NYSE:LLY) Mounjaro and Zepbound, and Novo Nordisk A/S’ (NYSE:NVO) Ozempic and Wegovy.

Despite limited insurance coverage and high out-of-pocket costs, demand for these medications is soaring.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.